Cargando…
Prospective Analysis on Survival Outcomes of Nonsmall Cell Lung Cancer Stages over Ⅲb Treated with HangAm-Dan
BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) stages over Ⅲb still remain as an intractable disease. Survival rate of NSCLC stages over Ⅲb could be increased through chemotherapy and radiation, but results are not satisfactory. Oriental medicine herbal formula, HangAm-Dan (HAD) has be...
Autores principales: | JEONG, Tae-Young, PARK, Bong-Ky, LEE, Yeon-Weol, CHO, Chong-Kwan, YOO, Hwa-Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000501/ https://www.ncbi.nlm.nih.gov/pubmed/21081039 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.03 |
Ejemplares similares
-
A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus
por: Bang, Sun-Hwi, et al.
Publicado: (2012) -
Inhibition of lung cancer growth by HangAmDan-B is mediated by macrophage activation to M1 subtype
por: Park, Hye-Rin, et al.
Publicado: (2017) -
Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice
por: Kang, Hwa Jeong, et al.
Publicado: (2019) -
Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer
por: Jeon, Hyung-Joon, et al.
Publicado: (2015) -
Identification of Target Genes Involved in the Antiproliferative Effect of Enzyme-Modified Ginseng Extract in HepG2 Hepatocarcinoma Cell
por: Jang, Sung-Il, et al.
Publicado: (2013)